Replies to post #549464 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

The problem is that ASMs are not where news gets released and time is running short for NWBO to get news from a government regulator especially since many employees are already gearing up into vacation mode. They’re still working but time is running short to do much besides send an email saying it’s approved on manufacturing or whatever and even that can get delayed when an office is not running at full steam or the wrong person starts their Christmas vacation.

[manibiotech]

They are reasonable expectations . But given the history this ASM and this year will come to pass - just my opinion

[hyperopia]

dmb, I’m hopeful that we may get some clarification about the commercialization pathway and progress at the shareholder meeting. I agree that the commercial licensing of Sawston is likely a lynchpin event, and also doubt there’s a major issue. As I’ve posted previously here, and here, my hunch is that it may have to do with the computer validation of Flaskworks, and potentially other automated equipment. I recall that the initial license of Sawston was anticipated by the end of the 3rd quarter last year, but wasn’t received until the end of the 4th, so I anticipated there could be some delays with the commercial license as well - sometimes it’s just a matter of slotting into a busy regulator’s schedule after addressing issues that were raised during the inspection.

Happy Holidays and New Year to you as well